Mirabegron

CHEMBL2095212 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

396.5 g/mol

LogP

2.1

Phase

4

This medication relaxes the muscle in the bladder wall by activating specific receptors, reducing the urgency and frequency of urination. It is used to treat overactive bladder symptoms and is sometimes used in bladder cancer management.

Molekularmasse

396,5000 g/mol

LogP

2,10

TPSA

129,00 Å²

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Ovarian Cancer Benign Prostatic Hyperplasia Cardiovascular Disease Pain Management Non-Small Cell Lung Cancer Parkinson's Disease Multiple Sclerosis Obesity Lymphoma Type 2 Diabetes Hypertension Breast Cancer Chronic Pain Heart Failure Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1

InChI

InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1

Molecular Formula

C21H24N4O2S

HBD / HBA

4 / 6

Rotierbare Bindungen

9

Schwere Atome

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This medication relaxes the muscle in the bladder wall by activating specific receptors, reducing the urgency and frequency of urination. It is used to treat overactive bladder symptoms and is sometimes used in bladder cancer management.

Yes, Mirabegron is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2095212. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 9865528. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Mirabegron auf PillFYI

Struktur

Schnelldaten

Formel: C21H24N4O2S
Synonyme: 1

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.